2016 Review of the PIP Framework

(ARCHIVE: Please note that this page has been archived and is no longer updated.)

The PIP Advisory Group met in a Special Session on 13-14 October 2015 to seek views from Member States, industry and other stakeholders on the 2016 PIP Framework Review. The Advisory Group recommended that a small independent group of experts be established to review implementation of the PIP Framework using a transparent and inclusive approach. The Review was tasked with answering the following questions:

• What are the achievements since the PIP Framework was adopted?
• Has implementation of the PIP Framework improved global pandemic influenza preparedness, including interpandemic surveillance, and capacity to respond?
• What are the challenges, and possible ways of addressing them?

Beginning its work in January 2016, the Review Group held six meetings (four in-person), hosted two full-day consultations with Member States and stakeholders, conducted 40 interviews with key informants, and considered a number of written submissions. The Review Group provided its final report to the Director-General in October 2016 for consideration by the 140th Executive Board and the Seventieth World Health Assembly.

Members of the PIP Review Group

• Dr Christine Mwelwa Kaseba-Sata (Chair)
  Former WHO Goodwill Ambassador against Gender-based Violence, Zambia
• Professor William Kwabena Ampofo
  Head of Virology Department, Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana
• Dr Frances McGrath
  Chief Advisor, Clinical Leadership, Protection and Regulation, Ministry of Health, New Zealand
• Dr Talat Mokhtari-Azad
  Director, Iranian National Influenza Center
• Ms Johanne Newstead
  Head of Food Policy, Public Health Directorate, Department of Health, United Kingdom
• Dr Theresa Tam
  Deputy Chief Public Health Officer of the Public Health Agency of Canada
• Dr Viroj Tangcharoensathien
  Senior Adviser, International Health Policy Program, Ministry of Public Health, Thailand
• Professor Makarim Wibisono
  Chairman, Governing Board of Indonesia Council of World Affairs

First Meeting

• Meeting Report: 7 January 2016, via teleconference

Second meeting

• Meeting Report: 19 February 2016, via teleconference
• Debriefing on work of the PIP Framework Review Group, 23 February 2016

Third meeting

• 30 March 2016 meeting summary
• Meeting Report: 30 March - 1 April 2016, face-to-face meeting
• Presentation by the Chair
• Background document: Overview of the PIP Framework 2016 Review
• Debriefing on work of the PIP Framework Review Group, 30 March - 1 April 2016

Fourth meeting

• Meeting Report: 9-11 May 2016, face-to-face meeting

Fifth meeting

• Meeting Report: 27 June - 1 July 2016, face-to-face meeting
• Debriefing on work of the PIP Framework Review Group, 27 June - 1 July 2016

Sixth Meeting

• Meeting Report: 29 August - 2 September 2016, face-to-face meeting
• Webcast of session with Member States and stakeholders, 29 August 2016
• Debriefing on work of the PIP Framework Review Group, 2 September 2016
• Draft preliminary findings

Review Group Chair's presentation to the World Health Assembly

Dr Christine Mwelwa Kaseba-Sata, Review Group Chair, presented an update of the Review Group’s work at the Sixty-ninth World Health Assembly.

Final Report of the PIP Review Group

• PIP Review Group Report
  

Disclaimer

In order to enhance its management of Conflicts of Interest as well as strengthen public trust and transparency in connection with WHO meetings involving the provision of technical/normative advice, the names and brief biographies of individuals (“Published Information”) being considered for participation in such meetings are disclosed for public notice and comment.

The Published Information is provided by the experts themselves and is the sole responsibility of the individuals concerned. WHO is not responsible for the accuracy, veracity and completeness of the Published Information provided. Furthermore, in no event will WHO be responsible or liable for damages in relation to the use of, and reliance upon, the Published Information.

The comments received by WHO through the public notice and comment process are treated confidentially and their receipt will be acknowledged through a generic email notification to the sender. Comments and perceptions brought to the knowledge of WHO through this process are an integral component of WHO’s conflict of interest assessment policy and are carefully reviewed. WHO reserves the right to discuss information received through this process with the relevant expert with no attribution to the provider of such information. Upon review and assessment of the information received through this process, WHO, in its sole discretion, may take appropriate management action in accordance with its policies.

The participation of an expert in a WHO meeting does not imply that they are endorsed or recommended by the World Health Organization nor does it create a binding relationship between the expert and WHO.

The list of participating experts, a summary of relevant interests disclosed by such experts, and any appropriate mitigation measures taken by WHO relating to the management of conflicts of interests, will be reported publicly in accordance with WHO practice.